|
| | Publication Year | Title | Author(s) |
| 101 | 16-Nov-2012 | Biliary stenting versus surgical bypass for palliation of periampullary malignancy. | Nikfarjam, Mehrdad ; Hadj, Andrew K; Muralidharan, Vijayaragavan ; Tebbutt, Niall C ; Fink, Michael A ; Jones, Robert M ; Starkey, Graham; Vaughan, Rhys B ; Marshall, Alexander W; Christophi, Christopher |
| 102 | 31-Oct-2012 | Bevacizumab in colorectal cancer: current and future directions. | Yeung, Yvonne; Tebbutt, Niall C |
| 103 | 15-Apr-2011 | Biomarkers of 5-FU response in colon cancer. | Mariadason, John M ; Tebbutt, Niall C |
| 104 | 27-Jan-2011 | Risk of arterial thromboembolic events in patients with advanced colorectal cancer receiving bevacizumab. | Tebbutt, Niall C ; Murphy, F; Zannino, D; Wilson, K; Cummins, M M; Abdi, E; Strickland, A H; Lowenthal, R M; Marx, G; Karapetis, C; Shannon, J; Goldstein, David B; Nayagam, S S; Blum, R; Chantrill, L; Simes, R J; Price, Timothy J |
| 105 | 1-Dec-2010 | Strategies for overcoming inherent and acquired resistance to EGFR inhibitors by targeting downstream effectors in the RAS/PI3K pathway. | Weickhardt, Andrew J ; Tebbutt, Niall C ; Mariadason, John M |
| 106 | 1-Sep-2010 | Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity. | Chong, Geoffrey ; Tebbutt, Niall C |
| 107 | 1-Jun-2010 | Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study. | Tebbutt, Niall C ; Wilson, Kate; Gebski, Val J; Cummins, Michelle M; Zannino, Diana; van Hazel, Guy A; Robinson, Bridget; Broad, Adam; Ganju, Vinod; Ackland, Stephen P; Forgeson, Garry; Cunningham, David; Saunders, Mark P; Stockler, Martin R; Chua, Yujo; Zalcberg, John R; Simes, R John; Price, Timothy J |
| 108 | 12-Jan-2010 | Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial. | Tebbutt, Niall C ; Cummins, M M; Sourjina, T; Strickland, A; Van Hazel, G; Ganju, V; Gibbs, D; Stockler, M; Gebski, V; Zalcberg, John R |
| 109 | 13-Oct-2009 | Phase I biodistribution and pharmacokinetic study of Lewis Y-targeting immunoconjugate CMD-193 in patients with advanced epithelial cancers. | Herbertson, Rebecca A; Tebbutt, Niall C ; Lee, Fook-Thean; MacFarlane, David J; Chappell, Bridget; Micallef, Noel; Lee, Sze-Ting; Saunder, Timothy; Hopkins, Wendie; Smyth, Fiona E; Wyld, David K; Bellen, John; Sonnichsen, Daryl S; Brechbiel, Martin W; Murone, Carmel ; Scott, Andrew M |
| 110 | 19-Mar-2009 | 18F-FDG-PET imaging of a benign neurofibroma masquerading as metastatic oesophageal carcinoma. | Azad, Arun A; Chong, Geoffrey ; Tauro, A; Aly, Ahmad ; Tebbutt, Niall C |
| 111 | 23-Oct-2008 | Established, emerging and future roles of PET/CT in the management of colorectal cancer. | Herbertson, R A; Scarsbrook, A F; Lee, S T; Tebbutt, Niall C ; Scott, Andrew M |
| 112 | 1-Jun-2008 | Clinicians' attitudes towards management of metastatic colorectal adenocarcinoma. | Wong, Rachel; Wiley, Malcolm; Christophi, Christopher ; Tebbutt, Niall C |
| 113 | 10-Nov-2007 | Role of low-dose, noncontrast computed tomography from integrated positron emission tomography/computed tomography in evaluating incidental 2-deoxy-2-[F-18]fluoro-D-glucose-avid colon lesions. | Lee, S T; Tan, T; Poon, A M T; Toh, H B; Gill, S; Berlangieri, Salvatore U ; Kraft, E; Byrne, Amanda J; Pathmaraj, K ; O'Keefe, Graeme J; Tebbutt, Niall C ; Scott, Andrew M |
| 114 | 1-Jun-2007 | A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen. | Scott, Andrew M ; Tebbutt, Niall C ; Lee, Fook-Thean; Cavicchiolo, Tina; Liu, Zhanqi; Gill, Sanjeev; Poon, Aurora M T ; Hopkins, Wendie; Smyth, Fiona E; Murone, Carmel ; MacGregor, Duncan; Papenfuss, Anthony T; Chappell, Bridget; Saunder, Timothy H; Brechbiel, Martin W; Davis, Ian D; Murphy, Roger; Chong, Geoffrey ; Hoffman, Eric W; Old, Lloyd J |
| 115 | 13-Apr-2007 | The expanding role of PET technology in the management of patients with colorectal cancer. | Herbertson, R A; Lee, S T; Tebbutt, Niall C ; Scott, Andrew M |
| 116 | 6-Feb-2007 | Treatment of 5-fluorouracil refractory metastatic colorectal cancer: an Australian population-based analysis. | Damianovich, D; Adena, M; Tebbutt, Niall C |
| 117 | 17-Dec-2006 | Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus. | Davey, Rachel A; Tebbutt, Niall C ; Favaloro, Jenny M; O'neal, David N; Rae, Derek; Zajac, Jeffrey D ; Best, James D |
Loading...
2
0
20
0
false